期刊
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
卷 17, 期 6, 页码 810-820出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.bbmt.2011.01.002
关键词
Multiple myeloma; Interleukin-6 receptor; Fluorescence in situ hybridization; Prognosis; IL-6R blocker
资金
- Ministry of Health, Welfare and Family Affairs, Republic of Korea [0720440]
- Ministry of Education, Science, and Technology [20100020584]
- BK21 fellowship
- SNUH [04-2010-101]
Interleukin-6 (IL-6) is a potent pleiotropic cytokine that regulates plasma cell (PC) growth via the IL-6 receptor (IL-6R). We hypothesized that up-regulation of IL-6R in myeloma cells might confer the growth privilege to myeloma cells over bone marrow (BM) hematopoietic cells. We investigated the frequency and prognostic implication of increased copy number of the IL-6R gene by fluorescence in situ hybridization (FISH) in patients with newly diagnosed multiple myeloma (MM). One hundred two patients with newly diagnosed MM were enrolled. The FISH study for IL-6R was performed using a homemade bacterial artificial chromosome (BAC) probe for IL6R at chromosome Iq21. FISH signals were counted among BM plasma cells sorted by cytoplasmic immunoglobulin light chain staining (clg FISH). The amplification of IL-6R was detected in 53/102 patients (52.0%). The 5-year overall survival (OS) rate of patients with IL-6R gene amplification was 41.3% versus 44.8% for those with a normal IL-6R (P = .425). In 44 patients treated with high-dose chemotherapy and autologous stem cell transplantation (ASCT), patients with >= 3.1 copy numbers of IL-6R per PC showed adverse 5-year OS compared to those with <2.1 copies of IL-6R gene (44.4% versus 78.0%, P = .024). In multivariate analysis, the increase of IL-6R copy numbers (mean copy/PC >= 3.1) could be considered as an independent prognostic factor for MM patients who underwent ASCT. The gain of the IL-6R gene was frequent in myeloma, showing an association with adverse prognosis in myeloma patients treated with ASCT. These findings suggest the potential role of IL-6R in myeloma cell growth and therapeutic implications of the IL-6R blocker in the future. Biol Blood Marrow Transplant 17: 810-820 (2011) 2011 American Society for Blood and Marrow Transplantation
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据